Oral Dosing of GLP-1 Compounds
Application
US20260083678A1
Kind: A1
Mar 26, 2026
Inventors
Flemming S. Nielsen, Per Sauerberg
Abstract
The present invention relates to improved uses of GLP-1 peptides in oral therapy.
CPC Classifications
A61K 9/2013
A61K 9/0053
A61K 38/26
A61P 3/10
A61K 9/2054
A61K 31/166
A61P 3/04
Filing Date
2025-12-03
Application No.
19407705